Hints and tips:
...Q4, British American Tobacco FY, CMC Markets trading update and revised outlook for 2024, ConocoPhillips Q4, Compass Group Q1 trading update and AGM, Crédit Agricole FY, Honda Q3, Kering FY, L’Oreal FY,...
...Butantan is incorporating knowledge of new variants of coronavirus, which include the more contagious P.1 strain that has ravaged Brazil....
...France L&S and Italy will not pay dividends this year, and XL Bermuda is unlikely to. The slack is only partly taken up by France P&C which is over distributing....
...Idexx said in October that the animal health market had experienced a “V-shaped recovery”....
...With top-line beat flowing through the P&L, core op. profit was +8% vs cons and core EPS +12%. ¾ of the EBIT beat seems inventory related. Q: What were the most noteworthy areas in the results?...
...They include a mix of healthcare, consumer staples and tech: GlaxoSmithKline, Roche, ASML, Nestlé, Novartis, Novo Nordisk, L’Oréal, LVMH, AstraZeneca, SAP and Sanofi....
...AstraZeneca Sector: pharmaceuticals / HQ: cambridge, uk Key stat: $1bn — the funding secured to develop a vaccine from the US government....
...L, until the final CMA decision, expected on 11 May....
...Q4 2019 u/l PBT beat “rebased” consensus expectations by £111m (13%), though the outlook statement is somewhat sobering. ......
...company’s profit & loss (P&L) account....
...P&G’s line was “Being A Chinese Citizen”. KFC has provided Chinese style breakfasts. L’Oreal created cosmetics friendly to the Chinese skin....
...This centrifuged the smartest bankers out of Barcap and into Wall Street banks, leaving behind holes in the P&L and a bunch of plodders....
...(Financial Times) “Thousands more victims of Bernard L....
...Italian Beverage Company J J & D Wilkie James H Heal & Company JCB Backhoe Loader Business Unit JD Hughes Group Jomati Consultants Joseph Rhodes JSR Genetics K King Cole Kiveton Park Steel L...
...In pharmaceutical stocks, the trend has reversed since November with the weakest beating the strongest by 24 per cent....
...Persimmon took on 8 per cent to 318½p, while Bovis Homes rose 7.2 per cent to 400¾p....
...The Swiss broker advised clients to switch into rival AstraZeneca which it said was the only credible takeover target among Europe’s large pharmaceuticals companies....
...GW Pharmaceuticals added 4.6 per cent to 125½p on talk of a positive announcement at next week’s annual general meeting....
...As a part of these teams, we had reams and reams of information and data on generics, profit pools, what products are made, what the future is, what impact it would have on our P&L....
...It largely dismissed the regulator's claims of L&G mis-selling....
...GlaxoSmithKline was off 4 per cent at £11.51 and Shire Pharmaceuticals lost 2.5 per cent to 512½p....
International Edition